ERAS-4001

· Erasca, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ERAS-4001, covering 2025-12-03 to 2025-12-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors. [Phase 1]